P. Farina

540 total citations
30 papers, 453 citations indexed

About

P. Farina is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, P. Farina has authored 30 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Pharmacology and 7 papers in Pharmacology. Recurrent topics in P. Farina's work include Pharmacogenetics and Drug Metabolism (7 papers), Drug Transport and Resistance Mechanisms (4 papers) and Synthesis of Organic Compounds (4 papers). P. Farina is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Drug Transport and Resistance Mechanisms (4 papers) and Synthesis of Organic Compounds (4 papers). P. Farina collaborates with scholars based in Italy, United Kingdom and Switzerland. P. Farina's co-authors include Maurizio D’Incalci, Cristiana Sessa, Roberto Fanelli, Andreas Gescher, Barbara Leoni, A Tajana, E. Piazza, Maria Teresa Rocchetti, F. Cavalli and Costantino Mangioni and has published in prestigious journals such as British Journal of Pharmacology, Biochemical Pharmacology and Life Sciences.

In The Last Decade

P. Farina

29 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Farina Italy 11 202 165 86 81 53 30 453
Anne Wu United States 13 206 1.0× 78 0.5× 131 1.5× 67 0.8× 38 0.7× 19 651
Satoru Nagashima Japan 15 135 0.7× 66 0.4× 134 1.6× 72 0.9× 94 1.8× 41 565
Helen M. Dodds Australia 13 279 1.4× 174 1.1× 96 1.1× 25 0.3× 25 0.5× 26 479
Robert L. Thies Canada 13 216 1.1× 134 0.8× 51 0.6× 35 0.4× 38 0.7× 16 523
Jörg Pohl Germany 12 168 0.8× 190 1.2× 57 0.7× 31 0.4× 14 0.3× 15 687
Joan D. Ellis United States 14 129 0.6× 71 0.4× 98 1.1× 28 0.3× 39 0.7× 19 483
L.‐C. Chu United States 11 230 1.1× 50 0.3× 60 0.7× 114 1.4× 149 2.8× 13 660
Janet D. Peller United States 9 202 1.0× 62 0.4× 92 1.1× 24 0.3× 56 1.1× 10 501
Takefumi Shimizu Japan 13 128 0.6× 138 0.8× 44 0.5× 21 0.3× 28 0.5× 26 422
H Kinoshita Japan 16 124 0.6× 254 1.5× 84 1.0× 61 0.8× 18 0.3× 51 591

Countries citing papers authored by P. Farina

Since Specialization
Citations

This map shows the geographic impact of P. Farina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Farina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Farina more than expected).

Fields of papers citing papers by P. Farina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Farina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Farina. The network helps show where P. Farina may publish in the future.

Co-authorship network of co-authors of P. Farina

This figure shows the co-authorship network connecting the top 25 collaborators of P. Farina. A scholar is included among the top collaborators of P. Farina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Farina. P. Farina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Poggesi, Elena, Patrizia Angelico, P. Farina, et al.. (2008). Effect of selective antagonists of group I metabotropic glutamate receptors on the micturition reflex in rats. British Journal of Urology. 102(7). 890–898. 9 indexed citations
2.
Salem, Isam I., et al.. (2004). Selective and rapid liquid chromatography-mass spectrometry method for the determination of lercanidipine in human plasma. Journal of Chromatography B. 803(2). 201–207. 21 indexed citations
3.
Paniagua, M.J., María G. Crespo‐Leiro, L. de la Fuente, et al.. (2002). Prevention of cytomegalovirus disease after heart transplantation: preemptive therapy with 7 days’ intravenous ganciclovir. Transplantation Proceedings. 34(1). 69–70. 10 indexed citations
4.
Soma, Maurizio R., Elena Donetti, Roberta Baetta, et al.. (1998). Effect of lercanidipine and its (R)‐enantiomer on atherosclerotic lesions induced in hypercholesterolemic rabbits. British Journal of Pharmacology. 125(7). 1471–1476. 28 indexed citations
5.
Benfenati, Emilio, et al.. (1992). Mass spectrometric identification of urinary and plasma metabolites of 2-(6’-carboxyhexyl)-3-n-hexylcyclohexylamine, a new antiaggregating agent. European Journal of Drug Metabolism and Pharmacokinetics. 17(2). 93–101. 1 indexed citations
7.
Benfenati, Emilio, et al.. (1989). Metabolism and pharmacokinetics of p-(3,3-dimethyl-1-triazeno) benzoic acid in M5076 sarcoma-bearing mice. Cancer Chemotherapy and Pharmacology. 24(6). 354–358. 3 indexed citations
8.
Farina, P., et al.. (1989). New potential immunoenhancing compounds. Synthesis and pharmacological evaluation of new long-chain 2-amido-2-deoxy-D-glucose derivatives.. PubMed. 39(10). 1190–5. 3 indexed citations
9.
Farina, P., et al.. (1986). Comparison of metabolism and activity of an aryldimethyltriazene and an aryldiethyltriazene. Biochemical Pharmacology. 35(2). 209–215. 2 indexed citations
10.
Colombo, Tina, Maurizio D’Incalci, M.G. Donelli, et al.. (1985). Metabolic studies of a podophyllotoxin derivative (VP16) in the isolated perfused liver. Xenobiotica. 15(4). 343–350. 16 indexed citations
11.
D’Incalci, Maurizio, Cosmo Rossi, Cristiana Sessa, et al.. (1985). Pharmacokinetics of teniposide in patients with ovarian cancer.. PubMed. 69(1). 73–7. 16 indexed citations
12.
Colombo, Tina, Maurizio D’Incalci, P. Farina, et al.. (1983). Comparison of pharmacokinetics of vp16 in mice, rats and humans. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 292. 5 indexed citations
13.
Farina, P., et al.. (1983). Metabolism of the anticancer agent 1-(4-acetylphenyl)-3,3-dimethyltriazene. Journal of Mass Spectrometry. 10(8). 485–488. 6 indexed citations
14.
D’Incalci, Maurizio, P. Farina, & Cristiana Sessa. (1982). Pharmacokinetic of VP16 in humans. 1. 126–129. 3 indexed citations
15.
D’Incalci, Maurizio, P. Farina, Cristiana Sessa, C. Mangioni, & Silvio Garattini. (1982). Hexamethylmelamine distribution in patients with ovarian and other pelvic cancers.. PubMed. 66(2). 231–5. 10 indexed citations
16.
D’Incalci, Maurizio, Cristiana Sessa, & P. Farina. (1982). Clinical pharmacokinetics of VP16. 5 indexed citations
17.
Farina, P., et al.. (1981). High-performance liquid chromatography determination of 4′-demethyl-epipodophyllotoxin-9-(4,6-O-ethylidene β-d-glucopyranoside) (VP 16-213) in human plasma. Journal of Chromatography B Biomedical Sciences and Applications. 222(1). 141–145. 52 indexed citations
18.
D’Incalci, Maurizio, P. Farina, M Fasoli, & Silvia Marsoni. (1981). VP16 plasma levels after i.v. and two methods of oral administration to choriocarcinoma patients. 5 indexed citations
19.
Gescher, Andreas, Maurizio D’Incalci, Roberto Fanelli, & P. Farina. (1980). N-hydroxymethylpentamethylmelamine, a major metabolite of hexamethylmelamine. Life Sciences. 26(2). 147–154. 43 indexed citations
20.
Farina, P., Gianni Tognoni, & Umberto Cornelli. (1977). Pharmacokinetic profile of trithiozine, a new antisecretory drug, in man. European Journal of Drug Metabolism and Pharmacokinetics. 2(2). 97–100. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026